We have observed
12 EP applications
Rachel Ann Jones
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after January 17, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PEPTIDES, DEVICES, AND METHODS FOR THE DETECTION OF EHRLICHIA ANTIBODIES
SOLUBLE BACTERIAL AND FUNGAL PROTEINS AND METHODS AND USES THEREOF IN INHIBITING AND DISPERSING BIOFILM
RECOMBINANT FUSION PROTEIN FORMULATION
IN VITRO PRODUCTION OF EXPANDED POTENTIAL STEM CELLS
MENINGITIS B VACCINE
TARGETED EXPRESSION OF CHLORIDE CHANNELS AND METHODS OF USE THEREOF
CD200 INHIBITORS AND METHODS OF USE THEREOF
COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF
A RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS
VACCINES FOR HSV-2
ENDOPHYTE COMPOSITIONS AND METHODS FOR IMPROVEMENT OF PLANT TRAITS IN PLANTS OF AGRONOMIC IMPORTANCE